Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The record history now shows the latest revision (v3.5.4) as the current version, replacing the earlier v3.5.3 entry.
    Difference
    0.1%
    Check dated 2026-05-15T06:26:46.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site or interface version change rather than any update to the clinical trial record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:53:53.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:21:10.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the record history and Revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:52.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision history updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:10.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history; deletions remove a government-funding notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T12:14:14.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.